Patents Assigned to Dexcel Pharma Tech, Ltd
  • Venlafaxine formulations
    Patent number: 6703044
    Abstract: The invention provides a method for treating a subject with venlafaxine, comprising administering to the subject a formulation having a therapeutically effective amount of venlafaxine or a pharmaceutically acceptable salt thereof, wherein the formulation provides a delayed burst release after at least three hours resulting in dispersion mainly through the colon of the active ingredient into the blood stream as a result of colon absorption over a period of at least 24 hours.
    Type: Grant
    Filed: October 25, 2002
    Date of Patent: March 9, 2004
    Assignee: Dexcel Pharma Tech, Ltd
    Inventors: Adel Pinhasi, Mila Gomberg, Avi Avramoff